These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 21053238)
21. Specificity and reactive loop length requirements for crmA inhibition of serine proteases. Tesch LD; Raghavendra MP; Bedsted-Faarvang T; Gettins PG; Olson ST Protein Sci; 2005 Feb; 14(2):533-42. PubMed ID: 15632287 [TBL] [Abstract][Full Text] [Related]
22. Protein inhibitors of serine proteinases. Otlewski J; Krowarsch D; Apostoluk W Acta Biochim Pol; 1999; 46(3):531-65. PubMed ID: 10698264 [TBL] [Abstract][Full Text] [Related]
23. Apparent formation of sodium dodecyl sulfate-stable complexes between serpins and 3,4-dichloroisocoumarin-inactivated proteinases is due to regeneration of active proteinase from the inactivated enzyme. Olson ST; Swanson R; Patston PA; Björk I J Biol Chem; 1997 May; 272(20):13338-42. PubMed ID: 9148956 [TBL] [Abstract][Full Text] [Related]
24. [Creation of synthetic serine proteinase inhibitors, an important pharmacological problem]. Markwardt F Farmakol Toksikol; 1978; 41(5):530-3. PubMed ID: 359347 [No Abstract] [Full Text] [Related]
25. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Wilczynska M; Fa M; Karolin J; Ohlsson PI; Johansson LB; Ny T Nat Struct Biol; 1997 May; 4(5):354-7. PubMed ID: 9145103 [No Abstract] [Full Text] [Related]
26. A continuous-flow mass biosensor for the real-time dynamic analysis of protease inhibition. Huang Y; Zhang Q; Liu G; Zhao R Chem Commun (Camb); 2015 Apr; 51(30):6601-4. PubMed ID: 25776796 [TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of several small-size HTLV-I protease inhibitors with different hydrophilicity profiles. Nguyen JT; Kato K; Hidaka K; Kumada HO; Kimura T; Kiso Y Bioorg Med Chem Lett; 2011 Apr; 21(8):2425-9. PubMed ID: 21392990 [TBL] [Abstract][Full Text] [Related]
28. Structural and Antiviral Studies of the Human Norovirus GII.4 Protease. Muzzarelli KM; Kuiper B; Spellmon N; Brunzelle J; Hackett J; Amblard F; Zhou S; Liu P; Kovari IA; Yang Z; Schinazi RF; Kovari LC Biochemistry; 2019 Feb; 58(7):900-907. PubMed ID: 30605321 [TBL] [Abstract][Full Text] [Related]
29. Structure-based exploration and exploitation of the S Galasiti Kankanamalage AC; Kim Y; Rathnayake AD; Damalanka VC; Weerawarna PM; Doyle ST; Alsoudi AF; Dissanayake DMP; Lushington GH; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC Eur J Med Chem; 2017 Jan; 126():502-516. PubMed ID: 27914364 [TBL] [Abstract][Full Text] [Related]
31. Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics. Ogbu CO; Qabar MN; Boatman PD; Urban J; Meara JP; Ferguson MD; Tulinsky J; Lum C; Babu S; Blaskovich MA; Nakanishi H; Ruan F; Cao B; Minarik R; Little T; Nelson S; Nguyen M; Gall A; Kahn M Bioorg Med Chem Lett; 1998 Sep; 8(17):2321-6. PubMed ID: 9873535 [TBL] [Abstract][Full Text] [Related]
32. Proteases and their cognate inhibitors of the serine and metalloprotease subclasses, in testicular physiology. Le Magueresse-Battistoni B Adv Exp Med Biol; 2008; 636():133-53. PubMed ID: 19856166 [No Abstract] [Full Text] [Related]
33. Exploiting the unique features of Zika and Dengue proteases for inhibitor design. Majerová T; Novotný P; Krýsová E; Konvalinka J Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760 [TBL] [Abstract][Full Text] [Related]
34. Twenty-five years of nomenclature and classification of proteolytic enzymes. Rawlings ND Biochim Biophys Acta Proteins Proteom; 2020 Feb; 1868(2):140345. PubMed ID: 31838087 [TBL] [Abstract][Full Text] [Related]
35. The effects of Enterolobium contortisiliquum serine protease inhibitor on the survival of the termite Nasutitermes corniger, and its use as affinity adsorbent to purify termite proteases. da Silva Ferreira R; Napoleão TH; Silva-Lucca RA; Silva MCC; Paiva PMG; Oliva MLV Pest Manag Sci; 2019 Mar; 75(3):632-638. PubMed ID: 30051588 [TBL] [Abstract][Full Text] [Related]
36. Serpins and other covalent protease inhibitors. Ye S; Goldsmith EJ Curr Opin Struct Biol; 2001 Dec; 11(6):740-5. PubMed ID: 11751056 [TBL] [Abstract][Full Text] [Related]
37. Peptide length and leaving-group sterics influence potency of peptide phosphonate protease inhibitors. Brown CM; Ray M; Eroy-Reveles AA; Egea P; Tajon C; Craik CS Chem Biol; 2011 Jan; 18(1):48-57. PubMed ID: 21276938 [TBL] [Abstract][Full Text] [Related]
39. Discovery of nonpeptide, peptidomimetic peptidase inhibitors that target alternate enzyme active site conformations. Rich DH; Bursavich MG; Estiarte MA Biopolymers; 2002; 66(2):115-25. PubMed ID: 12325161 [TBL] [Abstract][Full Text] [Related]
40. CoMFA investigations on two series of artificial peptide inhibitors of the serine protease thermitase. Synthesis of an inhibitor of predicted greater potency. Brandt W; Lehmann T; Willkomm C; Fittkau S; Barth A Int J Pept Protein Res; 1995 Jul; 46(1):73-8. PubMed ID: 7558600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]